From: FDG PET/CT in follow UP patients with colorectal carcinoma after adjuvant chemotherapy
 | Pathology | Test value | P-value | Sig. |
---|---|---|---|---|
Adenocarcinoma | Mucinous | |||
No. = 26 | No. = 4 | |||
Recurrence | Positive | 0.192* | 0.661 | NS |
 |  | 16 (61.5%) | 2 (50.0%) |  |
Local spread | Positive | 0.192* | 0.661 | NS |
 |  | 16 (61.5%) | 2 (50.0%) |  |
Metastases | Positive | 6.036* | 0.014 | S |
 |  | 17 (65.4%) | 0 (0.0%) |  |
Hepatic deposits | Positive | 3.077* | 0.079 | NS |
 |  | 12 (46.2%) | 0 (0.0%) |  |
Pulmonary deposits | Positive | 1.678* | 0.195 | NS |
 |  | 8 (30.8%) | 0 (0.0%) |  |
Local LNs | Positive | 0.192* | 0.661 | NS |
 |  | 16 (61.5%) | 2 (50.0%) |  |
Distant LNs | Positive | 2.672* | 0.102 | NS |
 |  | 11 (42.3%) | 0 (0.0%) |  |
Bone deposits | Positive | 1.154* | 0.283 | NS |
 |  | 6 (23.1%) | 0 (0.0%) |  |
Peritoneal deposits | Positive | 0.710* | 0.399 | NS |
 |  | 4 (15.4%) | 0 (0.0%) |  |
False + ve | Positive | 0.513* | 0.474 | NS |
 |  | 3 (11.5%) | 0 (0.0%) |  |
False –ve | Positive | 21.667* | 0.000 | HS |
 |  | 0 (0.0%) | 3 (75.0%) |  |